Sensitive methodologies such as allele-specific PCR (qualitative or quantitative) or high resolution melting curve analysis are therefore required to identify all potential pathological mutations within MPL exon 10 and incorporated into molecular diagnostic algorithms for JAK2 V617F-negative MPN [17]. This evidence concerns the gene MPL and myeloproliferative disorder.